Hi Scott,In a recent post to Outlander2 on this ATH thread you suggested he look at PAA as worth a look at as it was in the neurodegenerative space with excellent prospects. Have you ever looked at PER for Duchene Muscular Dystrophy with its ATL1102 product? It is well placed with its trials. The only negative is the discussions on its HC threads are pretty wild (like IMU and BRN).Hope I dont get moderated!
Hi Scott,In a recent post to Outlander2 on this ATH thread you...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.60M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.288K | 257.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 97593686 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31319254 | 17 |
View Market Depth
| Last trade - 09.59am 26/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |